• About Us
    • Company History
    • Vision & Values
  • Services
    • At a Glance
    • In vitro DMPK & Pharmacology
      • Physicochemical Properties
      • Chemical Stability
      • In vitro Binding
      • Metabolic Stability
      • Permeability & Transporter Services
      • Reaction Phenotyping
      • CYP Inhibition
      • CYP Induction
      • Pharmacology Assay Development
      • Customised Laboratory Services
    • PK, Bioanalysis & Metabolite Identification
      • Bioanalysis Overview
      • Bioanalysis Services
      • Metabolite Identification
      • Pharmacokinetics (PK)
      • Metabolite Bulk-Up & Isolation (mg to g)
    • Modelling & Simulation
    • ADME Packages
      • Pharmacokinetics
      • Absorption
      • Oral Exposure
      • Human PK & Dose Prediction
    • Formulation Services
    • Due Diligence
      • Hit/Lead Compounds
      • Clinical Candidate
  • Latest
    • Blog
    • Events
    • News
  • Partners
    • Axis BioServices
    • BioAscent
    • Charnwood Molecular
    • Medicines Discovery Catapult
    • Reach Separations
    • Saretius
    • TherapeutAix
  • Meet The Team
  • Resources
    • Articles
    • Posters
    • Presentations
    • Publications
    • Videos
  • Contact Us
  • Join Us
XenoGesis XenoGesis
  • About Us
    • Company History
    • Vision & Values
  • Services
    • At a Glance
    • In vitro DMPK & Pharmacology
      • Physicochemical Properties
      • Chemical Stability
      • In vitro Binding
      • Metabolic Stability
      • Permeability & Transporter Services
      • Reaction Phenotyping
      • CYP Inhibition
      • CYP Induction
      • Pharmacology Assay Development
      • Customised Laboratory Services
    • PK, Bioanalysis & Metabolite Identification
      • Bioanalysis Overview
      • Bioanalysis Services
      • Metabolite Identification
      • Pharmacokinetics (PK)
      • Metabolite Bulk-Up & Isolation (mg to g)
    • Modelling & Simulation
    • ADME Packages
      • Pharmacokinetics
      • Absorption
      • Oral Exposure
      • Human PK & Dose Prediction
    • Formulation Services
    • Due Diligence
      • Hit/Lead Compounds
      • Clinical Candidate
  • Latest
    • Blog
    • Events
    • News
  • Partners
    • Axis BioServices
    • BioAscent
    • Charnwood Molecular
    • Medicines Discovery Catapult
    • Reach Separations
    • Saretius
    • TherapeutAix
  • Meet The Team
  • Resources
    • Articles
    • Posters
    • Presentations
    • Publications
    • Videos
  • Contact Us
  • Join Us
Latest News

MDC Drug Discovery Webinar Series – available online

June 22, 2020
suecarr 2020-06-22T14:50:13+00:00
Latest News

LUNAC Therapeutics selects XenoGesis as strategic drug discovery partner

June 3, 2020
suecarr 2020-06-03T22:42:30+00:00
Latest News

Dr Rachel Hemsley joins University of Oxford’s Experts in Residence Scheme

May 22, 2020
suecarr 2020-05-22T13:11:20+00:00
Latest News

Expert CROs join forces to support the discovery and development of new therapeutics during the pandemic

May 5, 2020
suecarr 2020-05-05T11:21:18+00:00
Latest News

XenoGesis receives Queen’s Award for Enterprise in recognition of export growth

April 21, 2020
suecarr 2020-04-21T05:59:16+00:00
Latest News, Uncategorized

XenoGesis supports Sitryx in the Discovery and Development of Immunometabolic Medicines

April 14, 2020
suecarr 2020-04-14T16:56:56+00:00
Latest News

Medicines Discovery Catapult launch webinar series

April 14, 2020
suecarr 2020-04-14T15:12:11+00:00
Latest News, Uncategorized

XenoGesis identified as ‘one to watch’ in Alantra’s Pharma Fast 50

March 6, 2020
suecarr 2020-03-06T11:38:21+00:00
Latest News

XenoGesis shortlisted as national finalist for Export Achievement

February 3, 2020
suecarr 2020-02-03T15:44:10+00:00
Latest News, Uncategorized

XenoGesis expands bioanalytical capacity with the purchase of two new mass specs

January 29, 2020
suecarr 2020-01-29T15:22:36+00:00

Posts navigation

1 2 3 Next Page
Contact Us
XenoGesis Ltd
  • BioCity Nottingham, Pennyfoot Street, Nottingham, Nottinghamshire, NG1 1GF, United Kingdom
  • BioHub, Alderley Park, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Telephone: +44 (0)115 837 0626
  • Email: info@xenogesis.com
Services
  • In vitro DMPK & Pharmacology
  • PK, Bioanalysis & Metabolite Identification
  • Modelling & Simulation
  • ADME Packages
  • Formulation Services
  • Due Diligence
Latest News
  • MDC Drug Discovery Webinar Series – available online
  • LUNAC Therapeutics selects XenoGesis as strategic drug discovery partner
  • Dr Rachel Hemsley joins University of Oxford’s Experts in Residence Scheme
Follow Us

© 2019 XenoGesis | BioCity Nottingham | Pennyfoot Street | Nottingham | NG1 1GF | UK

  • Privacy Policy

Our site uses cookies. Learn more about our use of cookies: cookie policy

I accept